Skip to main navigation Skip to search Skip to main content

Investigating the role of exosomal miRNAs in regulating B cell activation andautoantibody production in Malaysian individuals with rheumatoid arthritis

  • Ministry of Higher Education (MOHE)
  • Monash University Malaysia (MUM)
  • Sunway University
  • Sunway Medical Centre

Project: Research

Project Details

Description

Rheumatoid arthritis (RA) is characterised by the presence of autoantibodies in the serum. Rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPA) are two autoantibodies for diagnosing and classifying RA. Although RF and/or ACPA positivity is present in 50-70% of RA patients, the remaining 30-50% may have low levels of these autoantibodies or be undetectable by either test. The discrepancy in autoantibody levels among RA patients is currently not well understood, making the RA diagnosis more challenging. Based on our preliminary data, it appears that exosomal miRNAs have a significant association with the disease activity of RA patients. However, the mechanisms by which exosomal miRNAs exert their regulatory functions are still unclear. Therefore, our hypothesis is that exosomal miRNAs play a crucial role in regulating B cell activation and controlling the production of undesired autoantibodies from plasma cells. The proposed study aims to identify exosomal miRNAs in specific B-cell subsets derived from peripheral blood mononuclear cells (PBMCs) of RA patients using RNA-seq, and determine their target genes through the use of bioinformatic tools. Additionally, we investigate exosomal miRNAs that are significantly expressed in B cell subsets for their ability to activate B cell proliferation and differentiation using cell proliferation assays and flow cytometry. ELISA is also conducted to measure the production of ACPA before and after the treatment of exosomal miRNAs in B cell subsets. Our findings will provide additional insights into the pathogenesis of RA, and the identified exosomal miRNAs can potentially serve as novel biomarkers to detect the early stages of RA when autoantibody is not detectable. Early detection of RA can lead to early treatment that significantly reduces pain, immobility, and joint deformity, ultimately improving the quality of life for individuals in the Malaysian community.
StatusFinished
Effective start/end date1/10/23 → 30/09/26

Funding

  • Ministry of Higher Education (MOHE)

UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.